Pediatrix Medical (MD) Liabilities and Shareholders Equity (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $2.1 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 3.85% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (up 4.87% YoY) and the FY2025 annual result came in at $2.2 billion, up 4.37% from the prior year.
• Liabilities and Shareholders Equity fell to $2.1 billion in Q1 2026 per MD's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.4 billion in Q2 2022 and bottomed at $2.0 billion in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $2.2 billion (2023), against an average of $2.2 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity dropped 13.76%; it then grew 5.9% in 2025.
• Tracing MD's Liabilities and Shareholders Equity over 5 years: stood at $2.3 billion in 2022, then fell by 5.45% to $2.2 billion in 2023, then retreated by 3.02% to $2.2 billion in 2024, then increased by 4.37% to $2.2 billion in 2025, then dropped by 7.85% to $2.1 billion in 2026.
• Per Business Quant, the three latest MD Liabilities and Shareholders Equity figures stand at $2.1 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025).

Peer Comparison